Association of ferroportin Q248H polymorphism with elevated levels of serum ferritin in African Americans in the Hemochromatosis and Iron Overload Screening (HEIRS) Study

Charles A. Rivers, James C. Barton, Victor R. Gordeuk, Ronald T. Acton, Mark R. Speechley, Beverly M. Snively, Catherine Leiendecker-Foster, Richard Press, Paul C. Adams, Gordon D. McLaren, Fitzroy W. Dawkins, Christine E. McLaren, David M. Reboussin

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

The ferroportin (FPN1) Q248H polymorphism has been associated with increased serum ferritin (SF) levels in sub-Saharan Africans and in African Americans (AA). AA participants of the HEIRS Study who did not have HFE C282Y or H63D who had elevated initial screening SF (≥ 300 μg/L in men and ≥ 200 μg/L in women) (defined as cases) were frequency-matched to AA participants with normal SF (defined as controls) to investigate the association of the Q248H with elevated SF. 10.4% of cases and 6.7% of controls were Q248H heterozygotes (P = 0.257). Q248H homozygosity was observed in 0.5% of the cases and none of the controls. The frequency of Q248H was higher among men with elevated SF than among control men (P = 0.047); corresponding differences were not observed among women. This appeared to be unrelated to self-reports of a previous diagnosis of liver disease. Men with elevated SF were three times more likely than women with elevated SF to have Q248H (P = 0.012). There were no significant differences in Q248H frequencies in men and women control participants. We conclude that the frequency of the FPN1 Q248H polymorphism is greater in AA men with elevated SF than in those with normal SF.

Original languageEnglish (US)
Pages (from-to)247-252
Number of pages6
JournalBlood Cells, Molecules, and Diseases
Volume38
Issue number3
DOIs
StatePublished - May 2007

Fingerprint

Iron Overload
Hemochromatosis
Ferritins
African Americans
Serum
Apoferritins
metal transporting protein 1
Heterozygote
Self Report
Liver Diseases

Keywords

  • Genetics
  • Mutation
  • Transferrin saturation

ASJC Scopus subject areas

  • Molecular Biology
  • Molecular Medicine
  • Hematology

Cite this

Association of ferroportin Q248H polymorphism with elevated levels of serum ferritin in African Americans in the Hemochromatosis and Iron Overload Screening (HEIRS) Study. / Rivers, Charles A.; Barton, James C.; Gordeuk, Victor R.; Acton, Ronald T.; Speechley, Mark R.; Snively, Beverly M.; Leiendecker-Foster, Catherine; Press, Richard; Adams, Paul C.; McLaren, Gordon D.; Dawkins, Fitzroy W.; McLaren, Christine E.; Reboussin, David M.

In: Blood Cells, Molecules, and Diseases, Vol. 38, No. 3, 05.2007, p. 247-252.

Research output: Contribution to journalArticle

Rivers, CA, Barton, JC, Gordeuk, VR, Acton, RT, Speechley, MR, Snively, BM, Leiendecker-Foster, C, Press, R, Adams, PC, McLaren, GD, Dawkins, FW, McLaren, CE & Reboussin, DM 2007, 'Association of ferroportin Q248H polymorphism with elevated levels of serum ferritin in African Americans in the Hemochromatosis and Iron Overload Screening (HEIRS) Study', Blood Cells, Molecules, and Diseases, vol. 38, no. 3, pp. 247-252. https://doi.org/10.1016/j.bcmd.2006.12.002
Rivers, Charles A. ; Barton, James C. ; Gordeuk, Victor R. ; Acton, Ronald T. ; Speechley, Mark R. ; Snively, Beverly M. ; Leiendecker-Foster, Catherine ; Press, Richard ; Adams, Paul C. ; McLaren, Gordon D. ; Dawkins, Fitzroy W. ; McLaren, Christine E. ; Reboussin, David M. / Association of ferroportin Q248H polymorphism with elevated levels of serum ferritin in African Americans in the Hemochromatosis and Iron Overload Screening (HEIRS) Study. In: Blood Cells, Molecules, and Diseases. 2007 ; Vol. 38, No. 3. pp. 247-252.
@article{0ab34a220cc542dabc40d6ed6b73714d,
title = "Association of ferroportin Q248H polymorphism with elevated levels of serum ferritin in African Americans in the Hemochromatosis and Iron Overload Screening (HEIRS) Study",
abstract = "The ferroportin (FPN1) Q248H polymorphism has been associated with increased serum ferritin (SF) levels in sub-Saharan Africans and in African Americans (AA). AA participants of the HEIRS Study who did not have HFE C282Y or H63D who had elevated initial screening SF (≥ 300 μg/L in men and ≥ 200 μg/L in women) (defined as cases) were frequency-matched to AA participants with normal SF (defined as controls) to investigate the association of the Q248H with elevated SF. 10.4{\%} of cases and 6.7{\%} of controls were Q248H heterozygotes (P = 0.257). Q248H homozygosity was observed in 0.5{\%} of the cases and none of the controls. The frequency of Q248H was higher among men with elevated SF than among control men (P = 0.047); corresponding differences were not observed among women. This appeared to be unrelated to self-reports of a previous diagnosis of liver disease. Men with elevated SF were three times more likely than women with elevated SF to have Q248H (P = 0.012). There were no significant differences in Q248H frequencies in men and women control participants. We conclude that the frequency of the FPN1 Q248H polymorphism is greater in AA men with elevated SF than in those with normal SF.",
keywords = "Genetics, Mutation, Transferrin saturation",
author = "Rivers, {Charles A.} and Barton, {James C.} and Gordeuk, {Victor R.} and Acton, {Ronald T.} and Speechley, {Mark R.} and Snively, {Beverly M.} and Catherine Leiendecker-Foster and Richard Press and Adams, {Paul C.} and McLaren, {Gordon D.} and Dawkins, {Fitzroy W.} and McLaren, {Christine E.} and Reboussin, {David M.}",
year = "2007",
month = "5",
doi = "10.1016/j.bcmd.2006.12.002",
language = "English (US)",
volume = "38",
pages = "247--252",
journal = "Blood Cells, Molecules, and Diseases",
issn = "1079-9796",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Association of ferroportin Q248H polymorphism with elevated levels of serum ferritin in African Americans in the Hemochromatosis and Iron Overload Screening (HEIRS) Study

AU - Rivers, Charles A.

AU - Barton, James C.

AU - Gordeuk, Victor R.

AU - Acton, Ronald T.

AU - Speechley, Mark R.

AU - Snively, Beverly M.

AU - Leiendecker-Foster, Catherine

AU - Press, Richard

AU - Adams, Paul C.

AU - McLaren, Gordon D.

AU - Dawkins, Fitzroy W.

AU - McLaren, Christine E.

AU - Reboussin, David M.

PY - 2007/5

Y1 - 2007/5

N2 - The ferroportin (FPN1) Q248H polymorphism has been associated with increased serum ferritin (SF) levels in sub-Saharan Africans and in African Americans (AA). AA participants of the HEIRS Study who did not have HFE C282Y or H63D who had elevated initial screening SF (≥ 300 μg/L in men and ≥ 200 μg/L in women) (defined as cases) were frequency-matched to AA participants with normal SF (defined as controls) to investigate the association of the Q248H with elevated SF. 10.4% of cases and 6.7% of controls were Q248H heterozygotes (P = 0.257). Q248H homozygosity was observed in 0.5% of the cases and none of the controls. The frequency of Q248H was higher among men with elevated SF than among control men (P = 0.047); corresponding differences were not observed among women. This appeared to be unrelated to self-reports of a previous diagnosis of liver disease. Men with elevated SF were three times more likely than women with elevated SF to have Q248H (P = 0.012). There were no significant differences in Q248H frequencies in men and women control participants. We conclude that the frequency of the FPN1 Q248H polymorphism is greater in AA men with elevated SF than in those with normal SF.

AB - The ferroportin (FPN1) Q248H polymorphism has been associated with increased serum ferritin (SF) levels in sub-Saharan Africans and in African Americans (AA). AA participants of the HEIRS Study who did not have HFE C282Y or H63D who had elevated initial screening SF (≥ 300 μg/L in men and ≥ 200 μg/L in women) (defined as cases) were frequency-matched to AA participants with normal SF (defined as controls) to investigate the association of the Q248H with elevated SF. 10.4% of cases and 6.7% of controls were Q248H heterozygotes (P = 0.257). Q248H homozygosity was observed in 0.5% of the cases and none of the controls. The frequency of Q248H was higher among men with elevated SF than among control men (P = 0.047); corresponding differences were not observed among women. This appeared to be unrelated to self-reports of a previous diagnosis of liver disease. Men with elevated SF were three times more likely than women with elevated SF to have Q248H (P = 0.012). There were no significant differences in Q248H frequencies in men and women control participants. We conclude that the frequency of the FPN1 Q248H polymorphism is greater in AA men with elevated SF than in those with normal SF.

KW - Genetics

KW - Mutation

KW - Transferrin saturation

UR - http://www.scopus.com/inward/record.url?scp=34047198023&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34047198023&partnerID=8YFLogxK

U2 - 10.1016/j.bcmd.2006.12.002

DO - 10.1016/j.bcmd.2006.12.002

M3 - Article

C2 - 17276706

AN - SCOPUS:34047198023

VL - 38

SP - 247

EP - 252

JO - Blood Cells, Molecules, and Diseases

JF - Blood Cells, Molecules, and Diseases

SN - 1079-9796

IS - 3

ER -